Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US
15 Oct 2024 //
FDA
Apopharma`s Generic Apremilast Receives Approval in the U.S.
24 Jan 2024 //
FDA
Patent Challenges for ApoPharma’s Ferriprox and Akorn’s Zioptan
30 Mar 2016 //
TWOFOUR INSIGHT
ApoPharma Announces Health Canada Approval of Ferriprox (deferiprone)
17 Feb 2015 //
APOTEX